A novel method for the detection, quantitation, and breakpoint cluster region determination of t(15;17) fusion transcripts using a one-step real-time multiplex RT-PCR

American Journal of Clinical Pathology

Volumn 119, Issue 1, 2003, Pages 137-144

  Choppa, Paul C ^b   Gomez, Jamie ^b   Vall, Horacio G ^b   Owens, Marilyn ^b   Rappaport, Henry ^b   Lopategui, Jean R ^a  

^a IMPATH   (United States)

^b NONE

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; APL; Real time quantitative RT PCR; Reverse transcriptase polymerase chain reaction

Indexed keywords

RETINOIC ACID; RNA; BCR ABL PROTEIN; DNA; PRIMER DNA;

ACUTE LEUKEMIA; ALTERNATIVE RNA SPLICING; ARTICLE; BLOOD; BONE MARROW; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME BREAKPOINT CLUSTER REGION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; GENE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PML GENE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; CHEMISTRY; CHROMOSOME BREAKAGE; DNA PROBE; GENE TRANSLOCATION; GENETICS; METHODOLOGY; PATHOLOGY;

CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; DNA PRIMERS; DNA PROBES; DNA, NEOPLASM; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSLOCATION, GENETIC;

EID: 85047689037     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/KBLQ883YXQMAFCAH     Document Type: Article

References (26)

1. de The H, Chomienne C, Lanotte M, et al. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature. 1990;347:558-561.
2. Kakizuka KA, Miller WH Jr, Umesono K, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcriptional factor, PML. Cell. 1991;66:663-674.
3. de The H, Lavau C, Marchio A, et al. The PML-RARalpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 1991;66:675-684.
4. Borrow J, Goddard AD, Sheer D, et al. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science. 1990;249:1577-1580.
5. Pandolfi PP, Alcalay M, Fagioli M, et al. Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukemia. EMBO J. 1992;11:1397-1407.
6. Dong S, Geng JP, Tong JH, et al. Breakpoint clusters of the PML gene in acute promyelocytic leukemia: primary structure of the reciprocal products of the PML/RAR alpha gene in patients with t(15;17). Genes Chromosomes Cancer. 1993;6:133-139.
7. Tong JH, Dong S, Geng JP, et al. Molecular rearrangements of the myl gene in acute promyelocytic leukemia (APL M3) define a breakpoint cluster region as well as some molecular variants. Oncogene. 1992;7:311-316.
8. Chen SJ, Chen Z, Chen A, et al. Occurrence of distinct PML-RARalpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase polymerase chain reaction. Oncogene. 1992;7:1223-1232.
9. Miller WH Jr, Kakizuka A, Frankel SR, et al. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor a clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1992;89:2694-2698.
10. Fukutani H, Naoe T, Yoshida H, et al. Molecular heterogeneity of the PML gene rearrangement in acute promyelocytic leukemia: prevalence and clinical significance. Jpn J Cancer Res. 1993;84:257-264.
11. Gallagher RE, Li Y-P, Rao S, et al. Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood. 1995;86:1540-1547.
12. Gallagher RE, Willman CL, Slack JL, et al. Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study. Blood. 1997;90:1656-1663.
13. Rennert H, Golde T, Wilson RB, et al. A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: a comparative study of RT-PCR, cytogenetics, and fluorescence in situ hybridization. Mol Diagn. 1999;4:195-209.
14. Huang W, Sun G-L, Li X-S, et al. Acute promyelocytic leukemia: clinical relevance of two major PML-RARalpha isoforms and detection of minimal residual disease by reverse transcriptase polymerase chain reaction to predict relapse. Blood. 1993;82:1264-1269.
15. Vahdat L, Maslak P, Miller WH Jr, et al. Early mortality and retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low dose chemotherapy, PML-RARalpha isoforms and CD13 expression in patients treated with all-trans retinoic acid. Blood. 1994;84:3843-3849.
16. Jurcic JG, Nimer SD, Scheinberg DA, et al. Prognostic significance of minimal residual disease detection and PML-RARalpha isoform type: long term follow-up in acute promyelocytic leukemia. Blood. 2001;98:2651-2656.
17. Hussey CE, Lyon E, Millson A, et al. A rapid practical RT-PCR based approach for the detection of the PML/RAR alpha fusion transcript in acute promyelocytic leukemia. Am J Clin Pathol. 1999;112:256-262.
18. Miller WH Jr, Levine K, DeBlasio A, et al. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA. Blood. 1993;82:1689-1694.
19. Slack JL, Bi W, Livak KJ, et al. Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reaction. J Mol Diagn. 2001;3:141-149.
20. Biondi A, Rambaldi A, Pandolfi PP, et al. Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood. 1992;80:492-497.
21. Lanotte M, Martin-Thouvenin V, Najman S, et al. A maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood. 1991;77:1080-1086.
22. Slack JL, Willman CL, Andersen J, et al. Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129. Blood. 2000;95:398-403.
23. Cassinat B, Zassadowski F, Balitrand N, et al. Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR. Leukemia. 2000;14:324-328.
24. PE Applied Biosystems. Relative quantitation of gene expression. Foster City, CA: PE Applied Biosystems; 1997:16-24. User bulletin 2.
25. Oconnor S, Evans P, Morgan GJ. Diagnostic approaches to acute promyelocytic leukaemia. Leuk Lymphoma. 1999;33:53-63.
26. Foucar K. Bone Marrow Pathology. 2nd ed. Chicago, IL: ASCP Press; 2001.